The efficiency of treatment in patients with uterine-confined endometrial cancer

European Journal of Gynaecological Oncology

Volumn 27, Issue 6, 2006, Pages 579-584

  Karolewski, K ^a   Kojs, Z ^a   Urbanski K ^a   Jakubowicz, J ^a   Blecharz, P ^a   Dymek, P ^a   Reinfuss, M ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Treatment results; Uterine confined endometrial cancer

Indexed keywords

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; ENDOMETRIUM CANCER; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HISTOPATHOLOGY; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; POSTOPERATIVE CARE; TUMOR BIOPSY; UTERUS CANCER;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 33846535364     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Akcerman I., Malone S., Thomas G. et al.: "Endometrial carcinoma - relative effectiveness of adjuvant irradiation vs therapy reserved for relapse". Gynecol. Oncol., 1966, 60, 177.
2. Anderson J. M., Stea B., Hallum A. V. et al.: "High-dose-rate postoperative vaginal cuff irradiation alone for stage IB and IC endometrial cancer". Int. J. Radiat. Oncol. Biol. Phys., 2000, 46, 417.
3. Backe J., Gassel A. M., Hauber K. et al.: "P53 protein in endometrial cancer is related to proliferative and prognosis but not expression of p23 protein". Int. J. Gynecol. Pathol., 1997, 16, 361.
4. Barakat R.R.: "Contemporary issues in the management of endometrial cancer". Ca Cancer J. Clin., 1988, 48, 299.
5. Bolla M., de Cornulier J., Berland E. et al.: "Pathological prognostic factors in a series of 137 stage I TNM/UICC endometrial carcinomas". Radiother. Oncol., 1999, 53, 209.
6. Bonatz G., Luttes J., Hamann S. et al.: "Immunohistochemical assessment of p 170 provides prognostic information in endometrial carcinoma". Histopathology, 1999, 34, 43.
7. Bonnier P., Torre J.D., Khouzani A., Piana L.: "Traitement chirurgical des cancers de l'endometre aux stades I et II cliniques". Bull. Cancer/Radiother., 1992, 709, 475.
8. Cardenes H., Randall M.E.: "Clarity and confusion regarding adjuvant radiation therapy in early endometrial cancer". Gynecol. Oncol., 1999, 75, 1.
9. Carey M.S., O'Connell G.J., Johanson C.R. et al.: "Good outcome associated with a standardized treatment protocol using selective postoperative radiation in patients with clinical Stage I adenocarcinoma of the endometrium". Gynecol. Oncol., 1995, 57, 138.
10. Carl U.M., Bahnsen J., Edel B., Chandra A.: "The value of postoperative radiation therapy in FIGO Stage I and II endometrial cancer". Strahlenther. Onkol., 1995, 17, 322.
11. Charra-Brunaud C., Peiffert D., Hoffstetter S. et al.: "Curiethèrapie vaginal postoperatoire des adènocarcinomes de l'endomètre à bas dèbit de dose". Cancer Radiother., 1998, 2, 34.
12. Chassagne D., Sismondi P. Horiot J.C. et al.: "A glossary for reporting complications of treatment in gynecological cancers". Radiother. Oncol., 1993, 26, 195.
13. Corn B.W., Lanciano R.M., D'Agostino R. et al.: "The relationship of local and distant failure from endometrial cancer: defining a clinical paradigm". Gynecol Oncol., 1997, 66, 414.
14. Cox. D.R.: "Regression models and life-tables (with discussion)". J. R. Stat. Soc. B., 1972, 34, 187.
15. Creasman W.T., Morrow C.P., Bundy B.N. et al.: "Surgical pathologic spread patterns of endometrial cancer: a Gynecologic Oncology Group study". Cancer, 1987, 60, 2035.
16. Creutzberg C.L., van Putten W.L., Koper P.C. M. et al.: "Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomized trial". Lancet, 2000, 355, 1404.
17. Einhorn J.: "Radiotherapy for cancer. A critical review of the literature". Acta Oncol., 1997, 35 (suppl. 7), 81.
18. Elliott P., Green D., Coates A. et al.: "The efficacy of postoperative vaginal irradiation in preventing vaginal recurrence in endometrial cancer". Int. J. Gynecol. Cancer, 1994, 4, 84.
19. Eltabbakh G.H., Moore A.D.: "Survival of women with surgical stage II endometrial cancer". Gynecol. Oncol., 1999, 74, 80.
20. FIGO stages - 1988 revision (announcements). Gynecol. Oncol., 1989, 35, 125.
21. Garcia-Domenech R.V., Inesta J.M., Asins E. et al.: "Prognostic factors in endometrial carcinoma: risk groups and adjuvant radiotherapy". Eur. J. Gynaecol. Oncol., 1997, 18, 164.
22. Greven K.M., Corn B., Cose D. et al.: "Which prognostic factors influence the outcome of patients with surgically staged endometrial cancer treated with adjuvant radiation". Int. J. Radiat. Oncol. Biol. Phys., 1997, 39, 413.
23. Greven K.M., D'Agostino R.B. Jr., Lanciano R.M., Corn B.W.: "Is there a role for a brachytherapy vaginal cuff boost in the adjuvant management of patients with uterine - confined endometrial cancer?". Int. J. Radiat. Oncol. Biol. Phys., 1998, 42, 101.
24. Greven K.M.: "Tailoring radiation to the extent of disease for uterine - confined endometrial cancer". Semin. Radiat. Oncol., 2000, 10, 29.
25. Hachisuga T., Kaku T., Fukuda K. et al.: "The grading of lymphovascular space invasion in endometrial carcinoma". Cancer, 1999, 86, 2090.
26. Huguenin P., Baumert B., Lutolf U.M. et al.: "Curative radiotherapy in elderly patients with endometrial cancer. Patterns of relapse, toxicity and quality of life". Strahlenther. Onkol., 1999, 175, 309.
27. Irvin C., Levin W., Fyles A. et al.: "The role of adjuvant radiotherapy in carcinoma of the endometrium - results in 550 patients with pathologic Stage I disease". Gynecol. Oncol., 1998, 70, 247.
28. Jareczek-Fossa B.A.: "Postoperative irradiation in endometrial cancer: still a matter of controversy". Cancer Treat. Rev., 2001, 27, 19.
29. Jareczek-Fossa B., Badzio A., Jassem J.: "Surgery followed by radiotherapy in endometrial cancer: analysis of survival and patterns of failure". Int. J. Gynecol. Cancer, 1999, 9, 285.
30. Kloetzer K. H., Gunther R., Wendt T.: "The vaginal stump recurrence rate in endometrial carcinoma in relation to the target volume of postoperative HDR - afterloadin brachyterapy". Strahlenther. Onkol., 1997, 173, 13.
31. Kucera H., Vavra N., Weghaupt K.: "Benefit external irradiation in pathologic Stage I endometrial carcinoma: a prospective clinical trial of 605 patients who received postoperative vaginal irradiation and additional pelvic irradiation in the presence of unfavorable prognostic factors". Gynecol. Oncol., 1990, 38, 99.
32. Larson D.M., Broste S.K., Krawisz B.R.: "Surgery without radiotherapy for primary treatment of endometrial cancer". Obstet. Gynecol., 1998, 91, 355.
33. Lukes A.S., Kohler M.F., Pieper C.F. et al.: "Multivariate analysis of DNA ploidy, p53, and HER-2/neu prognostic factors in endometrial cancer". Cancer, 1994, 73, 2380.
34. Lybeert M.L., van Putten W.L.J., Brölman H.A.M., Coebergh J.N.N.: "Postoperative radiotherapy for endometrial carcinoma. Stage I. Wide variation in referral patterns but no effect on long-term survival in a retrospective study in southeast Netherlands". Eur. J. Cancer, 1988, 34, 586.
35. Morrow C.P., Budy B.M., Kurman R.J. et al.: "Relationship between surgical-pathological risk factors and outcome in clinical Stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study". Gynecol. Oncol., 1991, 40, 55.
36. Nag S., Ericksen B., Parikh S. et al.: "The American Brachytherapy Society recommendation for high-dose rate brachytherapy for carcinoma of the endometrium". Int. J. Radiat. Oncol. Biol. Phys., 2000, 48, 779.
37. Naumann R.W., Higgins R.V., Hall J.B.: "The use of adjuvant radiation therapy by members of the Society of Gynecology Oncologists". Gynecol. Oncol., 1999, 75, 4.
38. Pavy J.J., Denekamp J., Letschert J. et al.: "Late effects toxicity scoring: the SOMA scale". Radiother. Oncol., 1995, 35, 17.
39. Peiffert D., Hoffstetter S., Charra-Brunaud C.: "Curiethè rapie des cancers de l'endometre". Cancer Radiother., 2003, 7, 121.
40. Pernot M., Hoffstetter S., Peiffert D. et al.: "Pre-operative, postoperative and exclusive irradiation of endometrial adenocarcinoma. Strahlenther". Onkol., 1994, 17, 313.
41. Peto R., Pike H.G., Armitage P. et al.: "Design and analysis of randomized clinical trials requiring prolonged observation of each patients I. Analysis and examples". Br. J. Cancer, 1977, 35, 1.
42. Roberts J.A., Brunetto V.L., Key H.M. et al.: "A phase III randomized study of surgery vs. surgery plus adjunctive radiation therapy in intermediate-risk endometrial carcinoma". Gynecol. Oncol., 1998, 68, 135.
43. Rose P.G.: "Endometrial carcinoma". N. Engl. J. Med., 1996, 335, 640.
44. Rush S., Gal D., Potters L. et al.: "Pelvic control following external beam irradiation for surgical stage I endometrial adenocarcinoma" . Int. J. Radiat. Oncol. Biol. Phys., 1995, 33, 851.
45. Salvesen H.B., Iversen C.E., Akslen L.A.: "Prognostic significance of angiogenesis and K-67, p53 and p21 expression: a population-based endometrial carcinoma study". J. Clin. Oncol., 1999, 17, 1382.
46. Thomas L., Batailland A., Bremond A. et al.: "Standards, Options et Recommendations pour la radiothèrapie des patients atteintes de cancer de l'endometre". Cancer Radiother., 2001, 5, 163.
47. Weiss E., Hirnle P., Arnold-Bofinger H. et al.: "Adjuvant vaginal high-dose-rate afterloading alone in endometrial carcinoma: patients of relapse and side effects following low-dose therapy". Gynecol. Oncol., 1998, 71, 72.
48. Weiss E., Hirnle P., Arnold-Bofinger H. et al.: "Therapeutic outcome and relation of acute and late side effects in the adjuvant radiotherapy of endometrial carcinoma Stage I and II." Radiother. Oncol., 1999, 53, 37.
49. Zaino R.J., Kurman R.J., Kiana K.L., Morrow P.C.: "Pathologic models to predict outcome for women with endometrial adenocarcinoma". Cancer, 1996, 77, 1115.